Upgrade to SI Premium - Free Trial

UBS Downgrades GlaxoSmithKline (GSK:LN) (GSK) to Sell

November 14, 2022 5:23 AM
UBS analyst (Michael Leuchten downgraded ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change Downgrades Intl Ratings